Relationship Between Adiposity and Cardiovascular Risk Factors in Prevalent Hemodialysis Patients

Journal of Renal Nutrition

Volumn 19, Issue 5, 2009, Pages 357-364

  Kaysen, George A ^a,b,c   Kotanko, Peter ^a,d   Zhu, Fansan ^a   Sarkar, Shubho R ^a,e   Heymsfield, Steven B ^f   Kuhlmann, Martin K ^a   Dwyer, Tjien ^b   Usvyat, Len ^a   Havel, Peter ^g   Levin, Nathan W ^a  

^a RENAL RESEARCH INSTITUTE   (United States)

^b Division of Nephrology   (United States)

^c VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^d KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CERULOPLASMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; MALE; MIDDLE AGED; MORTALITY; OBESITY; RENAL REPLACEMENT THERAPY; RISK FACTOR; SUBCUTANEOUS FAT;

ADIPONECTIN; ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CERULOPLASMIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; OBESITY; RENAL DIALYSIS; RISK FACTORS; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 68949184837     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.04.002     Document Type: Article

References (59)

1. Johansen K.L., Young B., Kaysen G.A., and Chertow G.M. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80 (2004) 324-332
2. Kalantar-Zadeh K., Kopple J.D., Kilpatrick R.D., et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46 (2005) 489-500
3. Kaysen G.A., Muller H.G., Young B.S., Leng X., and Chertow G.M. The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis. J Ren Nutr 14 (2004) 72-81
4. Wolfe R.A., Ashby V.B., Daugirdas J.T., Agodoa L.Y., Jones C.A., and Port F.K. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35 (2000) 80-88
5. Gotch F.A., Levin N.W., Port F.K., Wolfe R.A., and Uehlinger D.E. Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. Am J Kidney Dis 30 (1997) 1-15
6. Kotler D.P., Tierney A.R., Wang J., and Pierson Jr. R.N. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50 (1989) 444-447
7. Kamat A.M., Shock R.P., Naya Y., Rosser C.J., Slaton J.W., and Pisters L.L. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 63 (2004) 46-50
8. Le Blanc K., Ringden O., and Remberger M. A low body mass index is correlated with poor survival after allogeneic stem cell transplantation. Haematologica 88 (2003) 1044-1052
9. Curtis J.P., Selter J.G., Wang Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 10 165 (2005) 55-61
10. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. American Heart Association: National Heart, Lung, and Blood Institute definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
11. Ooi E.M., Watts G.F., Farvid M.S., et al. High-density lipoprotein apolipoprotein A-I kinetics in obesity. Obes Res 13 (2005) 1008-1016
12. Yeun J.Y., Levine R.A., Mantadilok V., and Kaysen G.A. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 (2000) 469-476
13. Zimmermann J., Herrlinger S., Pruy A., Metzger T., and Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55 (1999) 648-658
14. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 18 (2000) 1767-1772
15. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
16. Bastard J.P., Maachi M., Van Nhieu J.T., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87 (2002) 2084-2089
17. Hocher B., Ziebig R., Altermann C., et al. Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol 14 (2003) 2329-2337
18. Bologa R.M., Levine D.M., Parker T.S., et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32 (1998) 107-114
19. Koch M., Kutkuhn B., Grabensee B., Ritz E., and Apolipoprotein A. fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant 12 (1997) 2603-2611
20. Mekki K., Prost J., Bouchenak M., Remaoun M., and Belleville J. Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis. Atherosclerosis 169 (2003) 269-277
21. Lee D.M., Knight-Gibson C., Samuelsson O., Attman P.O., Wang C.S., and Alaupovic P. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. Kidney Int 61 (2002) 209-218
22. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
23. Ohashi N., Kato A., Misaki T., et al. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med 47 (2008) 485-491
24. Nordfors L., Lonnqvist F., Heimburger O., Danielsson A., Schalling M., and Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 54 (1998) 1267-1275
25. Daschner M., Tonshoff B., Blum W.F., et al. Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 9 (1998) 1074-1079
26. Bodary P.F., Gu S., Shen Y., Hasty A.H., Buckler J.M., and Eitzman D.T. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25 (2005) 3119-e122
27. Kougias P., Chai H., Lin P.H., Yao Q., Lumsden A.B., and Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 126 (2005) 121-129
28. Fruhbeck G. A heliocentric view of leptin. Proc Nutr Soc 60 (2001) 301-318
29. Singhal A., Farooqi I.S., Cole T.J., et al. Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation 106 (2002) 1919-1924
30. Havel P.J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53 Suppl 1 (2004) S143-S151
31. Cnop M., Havel P.J., Utzschneider K.M., Swarbrick M.M., and Havel P.J. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
32. Swarbrick M.M., and Havel P.J. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6 (2008) 87-102
33. Goldstein B.J., and Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 (2004) 2563-2568
34. Menon V., Li L., Wang X., et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2599-2606
35. Lee R.C., Wang Z., Heo M., Ross R., Janssen I., and Heymsfield S.B. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr 72 (2000) 796-803
36. Beckman Instruments, Inc.: Beckman instructions 015-248545-F, November 1994 (1994), Beckman Instruments, Inc., Brea, CA
37. Flannery W., Teukolsky B., and Vetterling W.T. Kolmogorov-Smirnov Test. Numerical recipes in FORTRAN: the art of scientific computing. 2nd ed. (1992), Cambridge University Press, Cambridge, UK 617-620
38. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355 (2006) 763-778
39. Pischon T., Boeing H., Hoffmann K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 359 (2008) 2105-2120
40. Wassink A.M., Olijhoek J.K., and Visseren F.L. The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest 37 (2007) 8-17
41. Davy K.P., and Hall J.E. Obesity and hypertension: two epidemics or one?. Am J Physiol Regul Integr Comp Physiol 286 (2004) R803-R813
42. Elsayed E.F., Sarnak M.J., Tighiouart H., et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52 (2008) 29-38
43. Elsayed E.F., Tighiouart H., Weiner D.E., et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 52 (2008) 49-57
44. Lang C.H., Dobrescu C., and Bagby G.J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130 (1992) 43-52
45. Ikewaki K., Schaefer J.R., Frischmann M.E., et al. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 2615-2622
46. Wang C., McConathy W.J., Kloer H.J., and Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins: effect of apolipoprotein C-III. J Clin Invest 75 (1985) 384-390
47. Brown W.V., and Baginsky M.L. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun 46 (1972) 375-382
48. Saland J.M., and Ginsberg H.N. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 22 (2007) 1095-1012
49. Lee D.M., Knight-Gibson C., Samuelsson O., Attman P.O., Wang C.S., and Alaupovic P. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. Kidney Int 61 (2002) 209-218
50. Lofgren I., Herron K., Zern T., et al. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. J Nutr 134 (2004) 1071-1076
51. Kimmel P.L., Phillips T.M., Simmens S.J., et al. Immunologic function and survival in hemodialysis patients. Kidney Int 54 (1998) 236-244
52. Stenvinkel P., Heimburger O., Lindholm B., Kaysen G.A., and Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15 (2000) 953-960
53. Pou K.M., Massaro J.M., Hoffmann U., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116 (2007) 1234-1241
54. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
55. Axelsson J., Rashid Qureshi A., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80 (2004) 1222-1229
56. Cignarelli M., DePergola G., Picca G., et al. Relationship of obesity and body fat distribution with ceruloplasmin serum levels. Int J Obes Relat Metab Disord 20 (1996) 809-813
57. Kaysen G.A., Dubin J.A., Müller H.G., et al. Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients. Kidney Int 63 (2003) 315-322
58. Rao M., Li L., Tighiouart H., Jaber B.L., Pereira B.J., and Balakrishnan V.S. Plasma adiponectin levels and clinical outcomes among haemodialysis patients. HEMO Study Group. Nephrol Dial Transplant 23 (2008) 2619-2628
59. Lo J.C., Go A.S., Chandra M., Fan D., and Kaysen G.A. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis 50 (2007) 552-558